|
|
||||||||
1 Department of Molecular Genetics, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai 980-8575, Japan
2 Research Center for Low Temperature and Materials Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan
3 Department of Chemistry, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan
4 Division of Chemistry, Graduate School of Engineering Science, Osaka University, Toyonaka, Osaka 560-8531, Japan
5 Laboratory of Radiation Biology, Department of Zoology, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The substrate specificity of NEIL1 overlaps that of NTH1, and thymine glycol (Tg) and 5-hydroxyuracil (OHU) are recognized by the proteins. In contrast to NTH1, NEIL1 partly catalyzes repair of 8-oxoguanine (8-oxoG) as well (Hazra et al. 2002a; Morland et al. 2002), whereas NEIL2 acts on certain oxidized products of pyrimidines (Hazra et al. 2002b). As mice deficient in NTH1 do now show any apparent phenotypic abnormalities (Takao et al. 2002b), NEIL1 is considered to be a back-up glycosylase for NTH1 in mice (Takao et al. 2002a). NEIL1 and NEIL2 remove oxidative damage, not only from double-stranded DNA (dsDNA) but also single-stranded DNA (ssDNA) (Takao et al. 2002a; Dou et al. 2003), whereas OGG1 and NTH1 act only on dsDNA. It has been suggested that they play a role in replication-associated repair or transcription-coupled repair (Dou et al. 2003) although the actual role and contribution of ssDNA BER in cells is still unclear. The mode of action of OGG1 and NTH1 is bifunctional, where the apurinic/apyrimidinic (AP) site resulting from the glycosylitic removal of a damaged base is further catalyzed to produce a ssDNA nick on the damaged strand by a β-elimination reaction. This reaction leaves 3'-unsaturated sugar residue and a normal 5'-phosphate. The former residues are removed by the major human AP endonuclease, APE1. In contrast, NEIL1 and NEIL2 catalyze a further
-elimination reaction which trims the 3'-sugar residues and leaves 3'-phosphate. The phosphate is considered to be removed by the 3'-phosphatase function of APE1, or polynucleotide kinase phosphatase. polynucleotide kinase phosphatase physically interacts with X-ray repair complementing 1 protein, which binds to polymerase β and Ligase III
, and is recognized as a molecular scaffold protein in DNA single-strand break repair (Caldecott, 2003). In the light of this interaction, the repair pathway involving NEIL1 and/or NEIL2 glycosylase has been vigorously studied (Camplans et al. 2005; Das et al. 2007; Guan et al. 2007; Dou et al. 2008).
The third Nei-like protein, NEIL3, is much less characterized than NEIL1 and NEIL2. NEIL3 has N-terminal Nei-like domain and an extra C-terminal domain. We have examined the DNA glycosylase activity of reticulocyte-translated NEIL3 toward Tg- and 8-oxoG-containing substrates and failed to detect any activity (Takao et al. 2002a). Another group has demonstrated that an extract from insect cells expressing human NEIL3 in a baculovirus expression system showed an excision activity for formamidopyrimidine (Fapy) residues, apparently higher than found in uninfected insect extract, but failed to detect the activity in vitro using recombinant protein from E. coli (Morland et al. 2002). Although they suggested that in vivo modification might be required for the activity of NEIL3, the DNA glycosylase activity and its repair function in vivo remain to be confirmed.
In this paper, we have characterized recombinant NEIL3 protein purified from E. coli, demonstrating its DNA-binding activity and AP-site nicking activity. A significant feature is that these activities are highly specific for ssDNA. We have further found that oxidative stress-sensitive E. coli nth nei could be partially rescued by NEIL3, suggesting E. coli-produced NEIL3 has a repair function for certain oxidative DNA lesions and/or base loss in ssDNA.
| Results |
|---|
|
|
|---|
NEIL3 consists of a putative N-terminal glycosylase domain (1–290; NEIL3GD) and a unique C-terminal domain (291–607; NEIL3CTD) (Fig. 1A). The latter domain shows no overall homology to known proteins, whereas it contains a zinc-finger motif and a short sequence homologous to an uncharacterized part of TOPOIII and APEXL2 (Tsuchimoto et al. 2001). NEIL3GD has helix-two-turn-helix (H2TH) and zinc finger (ZnF) motifs that are the hallmarks of Fpg-Nei glycosylase family (Sugahara et al. 2000) such as E. coli Fpg. The sequence identity to E. coli Fpg in the remaining part is, however, relatively weak, and the amino terminal proline which is strictly conserved in bacterial Fpg, Nei and vertebrate NEIL1 and NEIL2 glycosylases is replaced by valine in NEIL3. As the N-terminal proline is known to serve as the catalytic residue for DNA glycosylase function, it makes the enzymatic function of NEIL3 obscure. Thus we first tested the validity of NEIL3 as a DNA glycosylase enzyme by building a structural model. In addition to mammalian species, several vertebrate sequences for NEIL3 were found in EST and genome databases, including mammals, chicken, frog, and fish. We found that a 21-amino-acid stretch near the N-terminus of mammalian NEIL3 is absent in the frog (Silurana tropicalis) and fish (Fugu rubripes) counterparts, as illustrated by the alignment shown in Fig. 1B (human versus S. tropicalis sequence). The secondary structure prediction for human NEIL3 without the 21 residues (Q36 to L56) becomes very similar to that of S. tropicalis NEIL3 and the known structure folding of E. coli Fpg (Fig. 1B). Using the E. coli Fpg structure data as a template, an energy minimized model for human NEIL3GD was obtained (Fig. 1C). According to the model structure, positions of possible DNA interacting segments (i.e., turns between β2–β3, β4–β5, β7–β8, H2TH motif and ZnF motif) are predicted. Therefore, NEIL3GD may at least be a DNA interacting protein even though the N-terminal catalytic residue is altered.
|
We have found that NEIL3 produced by an in vitro translation system shows no glycosylase activity toward double-stranded Tg and 8-oxoG substrates (Takao et al. 2002a). However, the structural similarity suggests that NEIL3 may have other enzymatic features of Fpg-Nei glycosylase proteins such as DNA-binding or AP-lyase activities. To obtain more biochemical information, we generated full-length NEIL3 and NEIL3GD by expressing C-terminally 6xHis-tagged proteins in E. coli. Although NEIL3GD could be purified to near homogeneity, there were some difficulties regarding the expression and purification of the full-length NEIL3 protein. The yield and purity of soluble NEIL3 were less than NEIL3GD. The affinity-purified NEIL3 fraction contained polypeptides corresponding to the full-length protein (68 kDa) and its degradation product (50 kDa) as well as several bacterial protein contaminants as judged by SDS-PAGE and western blot analysis with
-6xHis antibody (a purity of the full-length NEIL3 polypeptide is approximately 20%). Thus, for the basic characterization we examined whether NEIL3GD possessed the characteristics of the full-length protein, and in some experiments described below, we shows data obtained from highly purified NEIL3GD.
The affinity-purified NEIL3GD fraction was subsequently subjected to heparin column chromatography. NEIL3GD eluted at 250 mM NaCl was readily visualized by Coomassie Brilliant Blue staining of SDS-PAGE (Fig. 2A, upper panel). However, these fractions did not bind to dsDNA (not shown). Instead, NEIL3GD showed binding activity to ssDNA (Fig. 2A, middle panel) as well as ssDNA containing an AP site analog, tetrahydrofuran (fAP), which is resistant to AP lyase-mediated strand incision (24) (Fig. 2A, lower panel). The specific binding of NEIL3GD to ssDNA was further confirmed by a competition assay (Fig. 2B). In this experiment, a 64 times molar excess of dsDNA did not compete with the single-stranded probe, indicating that the DNA binding of NEIL3GD is highly specific for the single-stranded form.
|
Glycosylitic release of oxidized bases by the Fpg-Nei glycosylase family is followed by the β–
elimination reaction of the associated AP lyase, resulting in a nick on the damaged strand. In the expectation that NEIL3 may have AP lyase activity, we carried out a DNA nicking assay with 30-mer oligonucleotide (oligo) containing a single AP site. When the single-stranded AP substrate (ssAP) was incubated with NEIL3GD or full-length NEIL3, products nicked at the AP site were observed with time (Fig. 3A or B, respectively). A double-stranded AP substrate (dsAP) was not susceptible to the AP lyase activity of NEIL3 (not shown). In a high-resolution sequencing gel, the products nicked by NEIL3GD were those of both β- and
-elimination (Fig. 3C). Therefore, NEIL3 has an incomplete but a potential activity of the β–
elimination reaction. NEIL3 showed lower nicking activity at the AP site than NEIL1 that was demonstrated with the identical substrate (Takao et al. 2002a). To avoid misinterpreting contaminating bacterial activities as the NEIL3 activity, we conducted a borohydride-trapping assay that detects a cross-linked product between a labeled DNA and protein, and can identify the protein species cross-linked to the probe on SDS-PAGE. The labeled ssAP substrate was incubated with the fraction containing full-length NEIL3 in the presence of NaBH4. As shown in Fig. 3D, the DNA-NEIL3 complex alone was detected at the expected size position, whereas any complex with bacterial enzymes, if contaminated, should appeared at lower than 50 kDa. Interestingly, the cross-link did not occur with double-stranded AP (dsAP) substrate paired with any nucleotide opposite the AP site (Fig. 3E). The ssDNA-specific AP lyase activity coincides with the ssDNA-specific DNA-binding activity (Fig. 2).
|
An enigmatic feature of NEIL3 is its amino terminal valine residue, while proline is strictly conserved among members of the Fpg-Nei glycosylase family and is essential for their glycosylase function. The third glutamic acid is also strictly conserved in the Fpg-Nei glycosylase family. It is, however, reported that substitution of the N-terminal Pro2 or Glu3 in bacterial Fpg or Nei does not destroy the AP lyase activity although the glycosylitic activity is lost (Lavrukhin & Lloyd 2000; Sidorkina & Laval 2000; Burgess et al. 2002). We evaluated the requirement of NEIL3 N-terminal residues for the AP lyase function (Fig. 4). In the borohydride-trapping assay, alteration of Val2 into the consensus proline context, NEIL3GD(V2P), and another alteration, NEIL3GD(V2T), retained the trapping activity. Similarly, a point mutant at Glu3, NEIL3GD(E3A), showed a trapped product. The residual activities in these mutants seem to imply less relevance of Val2 and Glu3 to the AP lyase activity of NEIL3 as is the case of Fpg and Nei mutants. In contrast to these amino acid substitutions, truncation of Val2 and Glu3, NEIL3GD(N
3), completely abolished the activity, suggesting that the appropriate length of the N-terminus seems to be required to keep the structure of the active site pocket. In addition to creating the N-terminal modifications, we disrupted the C-terminal ZnF motif. This motif in Fpg is an essential part of the DNA-binding region including Arg259 (Arg271 in NEIL3), which interacts directly with the damaged site. A deletion of the ZnF motif, NEIL3GD(
ZnF), or substitutions of cystein in the motif into serine, NEIL3GD(C276S) or NEIL3GD(C279S), resulted in complete loss of AP lyase activity. Mutation analysis mentioned above excludes a possibility that the recombinant polypeptide might invoke a non-catalytic reaction at the AP site (some basic molecules make cleavage at the site). The data rather imply that AP lyase activity of NEIL3GD is resulted from a correct protein folding, and support the validity of our structural modeling (Fig. 1C).
|
Several oxidative and some other base modifications at a defined position in the chemically synthesized 30 mer oligo were subjected to the trapping assay with the recombinant full-length NEIL3 and NEIL3GD. However, we were unable to find a substrate for NEIL3 among them in either the single-stranded or double-stranded form except for ssAP (Table 1 and Fig. 5). For example, Tg (either 5S or 5R isomer), a substrate extensively examined for Nth, Nei and NEIL1 (Katafuchi et al. 2004; Miller et al. 2004), was not catalyzed as demonstrated in Fig. 5 (lanes 1 and 2). Neither was a representative oxidative purine lesion, 8-oxoG, which is a good substrate for Fpg and OGG1 (lane 3).
|
|
Although we were not able to identify a substrate for DNA glycosylase activity in vitro, NEIL3 may play a certain repair role in vivo. To evaluate the in vivo function of NEIL3, we introduced NEIL3 cDNA into a E. coli nth nei double mutant strain which is sensitive to hydrogen peroxide (Saito et al. 1997). The vector used has a lac operon with a tac promoter. We applied a non-induced condition for the transformed cell culture to allow cells expressing mildly in the strain as mentioned (Aburatani et al. 1997). As shown in Fig. 6, E. coli with the vector alone showed no increase in resistance to hydrogen peroxide, while the full-length NEIL3 partially rescued the sensitive phenotype of the strain. The result was highly reproducible. Expression of NEIL3CTD did not change the sensitivity indicating that the CTD did not confer the resistant phenotype (not shown). These results strongly suggest that NEIL3 repairs a subset of oxidative base damage induced by hydrogen peroxide in E. coli.
|
We have previously examined mouse Neil1 expression in various tissues (Takao et al. 2002a). Using the same cDNA panel derived from BALB/c males (ages 8–12 weeks), tissue specific expression of mouse Neil3 was examined as shown in Fig. 7A (i.e., comparable with the previous data in Takao et al. 2002a). The expression was high in testis and spleen, and undetectable in many tissues, indicating a selective expression of mNeil3. In accordance with the results, Northern blot analysis of human NEIL3 has revealed the selective expression in testis and thymus (Morland et al. 2002). Embryonic expression of mNeil1 and mNeil3 was also examined (Fig. 7B). Although mNeil1 is constitutively expressed, mNeil3 shows increase in the expression level up to 15d and decline thereafter. The results suggest that the expression of mNeil3 depends on the developmental stage.
|
| Discussion |
|---|
|
|
|---|
NEIL3 has a long C-terminal sequence. Other members of the Fpg-Nei glycosylase family do not show such a C-terminal domain. Because the C-terminus of the 3D structural model of NEIL3GD is extruding from the core structure, NEIL3CTD is expected to form an additional domain structure. It would be of interest to know if NEIL3CTD might regulate the enzyme activity or function to direct the appropriate repair in vivo via interacting with other proteins.
Morland et al. (2002) showed that NEIL3 expressed by baculovirus system excised Fapy residues while NEIL3 expressed by E. coli system did not. In preliminary experiments, we failed to detect the incision activity of NEIL3 to methyl-Fapy, a methylated analog of Fapy, synthesized according to Asagoshi et al. (2000). Although one candidate for the NEIL3 substrate may be natural Fapy residues, in vivo complementation using E. coli nth nei suggests that NEIL3 can repair minor but lethal damage rather than Fapy because the strain retains intact Fpg and UvrABC which removes Fapy residues. Further studies, identifying the substrate specificities, will be needed.
Torisu et al. (2005) have established Neil3 knockout mice which are viable and fertile, and look healthy for at least 24 weeks after birth. Northern blot analyses of human and mouse have shown by them and others (Morland et al. 2002), indicating a specific expression in hematopoietic tissues. We also examined the tissue specificity for mouse Neil3 expression by quantitative (Q)-PCR and obtained similar results except for an abundant expression in testis where Torisu et al. (2005) barely detected in testis. As their mRNA and our cDNA were supplied by the same company (Clontech), the difference might be lot-to-lot variation. In any case, high expression of human NEIL3 in testis was reported by them and Morland et al. (2002). More recently, the details for several DNA glycosylases in brain by an in situ hybridization analysis have been demonstrated (Rolseth et al. 2008). The RNA for mNeil3 was detected in stem cell enriched regions of young mice and decreased with age (undetectable in brain 4 weeks after birth by Northern blot analysis). We further showed that the mNeil3 expression is dependent on the embryonic stage in contrast to the constitutive expression of mNeil1. The tissue-specific and development- and age-dependent expression patterns of NEIL3 are a unique character and might suggest an additional physiological role in such NEIL3-expressing cells and tissues.
| Experimental procedures |
|---|
|
|
|---|
The phosphoramidite chemicals for modified bases were obtained from Glen Research and the oligos containing a modified base were synthesized and purified. Those include fAP, OHU, 5,6-dihydrothymine (DHT), 5-hydroxymethyluracil (HMU), 8-oxoG, 2-oxoadenine (2-oxoA), O6-methylguanine (O6meG), ethenoadenine (
A), or uracil (U). Oligo containing Tg stereoisomers, 5S-6R (Tg(5S)) or 5R-6S (Tg(5R)) are synthesized as described (Iwai 2001). The sequence of the substrate is 5'-CTCGTCAGCATCTXCATCATACAGTCAGTG, where X is a modified base. The oligo was labeled using T4 polynucleotide kinase (Takara) with [
-32P] ATP (5000 Ci/mmol; Amersham Biosciences). A substrate containing a natural AP site was made by incubating the uracil-containing oligo with uracil DNA glycosylase, UDG (Invitrogen).
Protein modeling
The amino acid sequences of S. Tropicalis NEIL3 and human NEIL3 were sent to 3D-pssm website (http://www.sbg.bio.ic.ac.uk/servers/3dpssm/). Based on the predicted secondary structures, a sequence alignment between NEIL3 proteins and E. coli Fpg was made. The structure of E. coli Fpg (MutM, Protein Data code. entry 1k82 chain A) (Gilboa et al. 2002) was then used as a template for the homology modeling. The result of CLUSTAL Multiple Sequence Alignment was checked and repeated with the human NEIL3GD deletion model (21 amino acids, Q36 to L56). The substituted model coordinates were submitted to the 3D-pssm. The substitution from Fpg to the NEIL3 was carried out with program O (Jones et al. 1991). Deletions with respect to Fpg sequence were made interactively and energy-minimized locally using the graphic program O. The generated model was then energy minimized using the CNS software package (Brünger et al. 1998). The stereochemical quality of the final model was ensured using the program PROCHECK (Laskowski et al. 1993).
Expression and purification of recombinant NEIL3
Full-length NEIL3 and NEIL3GD (M1 to K281) cDNAs were subcloned in a pET21 vector (Novagen) to produce C-terminal 6xHis-tagged recombinant proteins. Deletion and substitution mutants were made by PCR with appropriate primers and subcloned in the same vector. All mutant clones were sequenced to verify the modifications. Production in E. coli BL21 CodonPlus (Stratagene) and affinity column (Ni-NTA, Qiagen) purification for the tagged protein from the lysate under native conditions was described previously (Takao et al. 2002a). The recombinant NEIL3GD was further purified on a HiTrap heparin HP column (Amersham) in a HPLC system (BioRad) and characterized for its DNA-binding activity and enzymatic activity.
DNA-binding assay
An electrophoretic mobility shift assay (EMSA) was used to examine the DNA-binding affinity of NEIL3. The labeled oligo was left single-stranded or annealed to the complementary strand. The heparin column fraction was incubated with the probe (5 nM) in a buffer of 25 mM HEPES–KCl (pH 7.4), 200 mM NaCl, 1 mM MgCl2, 0.5 mM dithiothreitol, 0.01% NP-40, 4% glycerol for 30 min on ice. The protein DNA complex was separated on a 6% non-denaturing polyacrylamide gel. In competition assays, single-stranded unmodified oligo, single-stranded fAP-oligo or double-stranded DNA fragment generated by cutting plasmid DNA with PvuII (i.e., blunt-ended) was preincubated on ice for 15 min as a competitor and mixed with the labeled probe as indicated above.
Incision assay and borohydride-trapping assay for AP lyase
The incision assay was carried out with the natural AP-site-containing substrate. The labeled substrate (5 fmol) was incubated with NEIL3 (100 ng) in 5 µL of buffer A (50 mM sodium phosphate (pH 7.5), 5 mM EDTA, 0.5 mM dithiothreitol) containing 100 mM NaCl at 30 °C for 30 min unless otherwise stated. The incision product was separated on a 20% polyacrylamide gel containing 7 M urea as described previously (Takao et al. 2002a). A borohydride-trapping assay (Zhang et al. 2000) was used to cross-link AP lyase and the labeled DNA substrate. The substrate (25 fmol) was incubated with NEIL3 (100 ng) in 20 µL of buffer A containing 100 mM sodium borohydride at 30 °C for 30 min. Glucose (6.7%) was added to quench the reaction. A portion was mixed with SDS loading buffer and run on a 5–20% gradient SDS polyacrylamide gel. In some experiments, 8 units of Fpg (NEB) was substituted for NEIL3, as a control for the borohydride-trapping reaction.
Complementation test of Escherichia coli mutant
NEIL3 cDNA was subcloned into a pUC-derived bacterial expression vector pFNc (Aburatani et al. 1997). Escherichia coli SY5 nth nei was transformed with the construct or with empty vector. Overnight cultures of the transformants were appropriately diluted and plated (0.1 mL) on LB agar plus ampicillin, containing hydrogen peroxide (0–1.5 mM). After incubation at 37 °C for about 40 h, the number of colonies was counted to estimate survival rate. The mean values from three independent experiments were plotted.
Quantitative PCR
Q-PCR was carried out with LightCycler instrument (Roche) as described (Takao et al. 2002a). A mouse multiple tissue cDNA panel (200 BALB/c males, age 8–12 weeks) and embryo cDNA panel (200 Swiss Webster/NIH embryos) were purchased from Clontech and further quantitated with amplimers for glyceraldehyde-3-phsphate dehydrogenase (Gapdh) as described previously (Takao et al. 2002a). Amplimers for Neil3 are 5'-ACTGAAT GGAGAGAAGATCCGGG and 5'-CAGCTCCTTCCCTAA GGTTTCCA.
| Acknowledgements |
|---|
| Footnotes |
|---|
aPresent address: Department of Biomolecular Engineering, Graduate School of Science and Technology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606–8585, Japan
| References |
|---|
|
|
|---|
Asagoshi, K., Yamada, T., Terato, H., Ohyama, Y., Monden, Y., Arai, T., Nishimura, S., Aburatani, H., Lindahl, T. & Ide, H. (2000) Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine. J. Biol. Chem. 275, 4956–4964.
Bandaru, V., Sunkara, S., Wallace, S.S. & Bond, J.P. (2002) A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair 17, 517–529.
Brünger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J., Rice, L.M., Simonson, T. & Warren, G.L. (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921.[CrossRef][Medline]
Burgess, S., Jaruga, P., Dodson, M.L., Dizdaroglu, M. & Lloyd, R.S. (2002) Determination of active site residues in Escherichia coli endonuclease VIII. J. Biol. Chem. 277, 2938–2944.
Caldecott, K.W. (2003) XRCC1 and DNA strand break repair. DNA Repair 18, 955–969.
Campalans, A., Marsin, S., Nakabeppu, Y., Oconnor, T.R., Boiteux, S. & Radicella, J.P. (2005) XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair 12, 826–835.
Das, A., Boldogh, I., Lee, J.W., Harrigan, J.A., Hegde, M.L., Piotrowski, J., de Souza Pinto, N., Ramos, W., Greenberg, M.M., Hazra, T.K., Mitra, S. & Bohr, V.A. (2007) The human Werner syndrome protein stimulates repair of oxidative DNA base damage by the DNA glycosylase NEIL1. J. Biol. Chem. 282, 26591–26602.
Dou, H., Mitra, S. & Hazra, T.K. (2003) Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2. J. Biol. Chem. 278, 49679–49684.
Dou, H., Theriot, C.A., Das, A., Hegde, M.L., Matsumoto, Y., Boldogh, I., Hazra, T.K., Bhakat, K.K. & Mitra, S (2008). Interaction of the human DNA glycosylase NEIL1 with proliferating cell nuclear antigen. The potential for replication-associated repair of oxidized bases in mammalian genomes. J. Biol. Chem. 283, 3130–3140.
Gilboa, R., Zharkov, D.O., Golan, G., Fernandes, A.S., Gerchman, S.E., Matz, E., Kycia, J.H., Grollman, A.P. & Shoham, G. (2002) Structure of formamidopyrimidine-DNA glycosylase covalently complexed to DNA. J. Biol. Chem. 277, 19811–19816.
Guan, X., Bai, H., Shi, G., Theriot, C.A., Hazra, T.K., Mitra, S. & Lu, A.L. (2007) The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase. Nucleic Acids Res. 35, 2463–2472.
Hazra, T.K., Izumi, T., Boldogh, I., Imhoff, B., Kow, Y.W., Jaruga, P., Dizdaroglu, M. & Mitra, S. (2002a) Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc. Natl Acad. Sci. USA 99, 523–528.
Hazra, T.K., Kow, Y.W., Hatahet, Z., Imhoff, B., Boldogh, I., Mokkapati, S.K., Mitra, S. & Izumi, T. (2002b) Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions. J. Biol. Chem. 277, 30417–30420.
Iwai, S. (2001) Synthesis and thermodynamic studies of oligonucleotides containing the two isomers of thymine glycol. Chemistry 7, 4343–4351.[CrossRef][Medline]
Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119.[CrossRef]
Katafuchi, A., Nakano, T., Masaoka, A., Terato, H., Iwai, S., Hanaoka, F. & Ide, H. (2004) Differential specificity of human and Escherichia coli endonuclease III and VIII homologues for oxidative base lesions. J. Biol. Chem. 279, 14464–14471.
Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283–291.[CrossRef]
Lavrukhin, O.V. & Lloyd, R.S. (2000) Involvement of phylogenetically conserved acidic amino acid residues in catalysis by an oxidative DNA damage enzyme formamidopyrimidine glycosylase. Biochemistry 39, 15266–15271.
Lindahl, T. & Wood, R.D. (1999) Quality control by DNA repair. Science 286, 1897–1905.
Miller, H., Fernandes, A.S., Zaika, E., McTigue, M.M., Torres, M.C., Wente, M., Iden, C.R. & Grollman, A.P. (2004) Stereoselective excision of thymine glycol from oxidatively damaged DNA. Nucleic Acids Res. 32, 338–345.
Morland, I., Rolseth, V., Luna, L., Rognes, T., Bjoras, M. & Seeberg, E. (2002) Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res. 30, 4926–4936.
Nilsen, H. & Krokan, H.E. (2001) Base excision repair in a network of defense and tolerance. Carcinogenesis 22, 987–998.
Rolseth, V., Rundén-Pran, E., Luna, L., McMurray, C., Bjørås, M. & Ottersen, O.P. (2008) Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains. DNA repair 7, 1578–1588.[Medline]
Saito, Y., Uraki, F., Nakajima, S., Asaeda, A., Ono, K., Kubo, K. & Yamamoto, K. (1997) Characterization of endonuclease III (nth) and endonuclease VIII (nei) mutants of Escherichia coli K-12. J. Bacteriol. 179, 3783–3785.
Sidorkina, O.M. & Laval, J. (2000) Role of the N-terminal proline residue in the catalytic activities of the Escherichia coli Fpg protein. J. Biol. Chem. 275, 9924–9929.
Sugahara, M., Mikawa, T., Kumasaka, T., Yamamoto, M., Kato, R., Fukuyama, K., Inoue, Y. & Kuramitsu, S. (2000) Crystal structure of a repair enzyme of oxidatively damaged DNA, MutM (Fpg), from an extreme thermophile, Thermus thermophilus HB8. EMBO J. 19, 3857–3869.[CrossRef][Medline]
Takao, M. & Yasui, A. (2005) DNA repair initiated by glycosylases in the nucleus and mitochondria of mammalian cells; how our cells respond to a flood of oxidative DNA damage. J. Dermatol. Sci. 1 (Suppl.), 9–19.
Takao, M., Kanno, S., Shiromoto, T., et al. (2002a) Novel nuclear and mitochondrial glycosylases revealed by disruption of the mouse Nth1 gene encoding an endonuclease III homolog for repair of thymine glycols. EMBO J. 21, 3486–3493.[CrossRef][Medline]
Takao, M., Kanno, S., Kobayashi, K., Zhang, Q.M., Yonei, S., van der Horst, G.T. & Yasui, A. (2002b) A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue. J. Biol. Chem. 277, 42205–42213.
Torisu, K., Tsuchimoto, D., Ohnishi, Y. & Nakabeppu, Y. (2005) Hematopoietic tissue-specific expression of mouse Neil3 for endonuclease VIII-like protein. J. Biochem. 138, 763–772.
Tsuchimoto, D., Sakai, Y., Sakumi, K., Nishioka, K., Sasaki, M., Fujiwara, T. & Nakabeppu, Y. (2001) Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen. Nucleic Acids Res. 29, 2349–2360.
Zhang, Q.M., Miyabe, I., Matsumoto, Y., Kino, K., Sugiyama, H. & Yonei, S. (2000) Identification of repair enzymes for 5-formyluracil in DNA. Nth, Nei, and MutM proteins of Escherichia coli. J. Biol. Chem. 275, 35471–35477.
Received: 12 August 2008
Accepted: 11 November 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |